<bill session="116" type="h" number="5927" updated="2020-07-13T18:41:38Z">
  <state datetime="2020-02-18">REFERRED</state>
  <status>
    <introduced datetime="2020-02-18"/>
  </status>
  <introduced datetime="2020-02-18"/>
  <titles>
    <title type="short" as="introduced">Safe Medicine Act</title>
    <title type="short" as="introduced">Safe Medicine Act</title>
    <title type="display">Safe Medicine Act</title>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to study American dependence on unsafe Chinese pharmaceuticals and to empower the Food and Drug Administration to mandate drug recalls in the case of critical contamination.</title>
  </titles>
  <sponsor bioguide_id="P000599"/>
  <cosponsors/>
  <actions>
    <action datetime="2020-02-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-02-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="unknown" number="5982"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Asia"/>
    <term name="China"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health information and medical records"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
